We're looking for a proactive Sales Operations Manager to lead our Customer Care and Operations Team. This role... combines effective sales management with operational efficiency, driving both customer satisfaction and significant revenue...
creates a range of career fields including manufacturing, research and development, technical services, sales and marketing... management as required. - Provide regular feedback and pro-active communication to the customer and/or sales representatives...
Director of Corporate Sales Development, Regional Sales VPs and Directors to develop and implement targeted territory... Sales Development Representatives including recruiting, hiring, and training new reps as well as developing and implementing...
2+ years of sales or account management experience - Experience deep diving on selling partner-level issues... - Experience analyzing data and best practices to assess performance drivers Global Sales' mission is to build new, inventive...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »